文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

研究人类 NK 细胞在人类实体瘤中作用的鼠类模型。

Murine models to study human NK cells in human solid tumors.

机构信息

Unità Operativa UO Patologia e Immunologia Sperimentale, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Animal Facility, IRCCS Ospedale Policlinico San Martino Genova, Genova, Italy.

出版信息

Front Immunol. 2023 Jun 14;14:1209237. doi: 10.3389/fimmu.2023.1209237. eCollection 2023.


DOI:10.3389/fimmu.2023.1209237
PMID:37388731
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10301748/
Abstract

Since the first studies, the mouse models have provided crucial support for the most important discoveries on NK cells, on their development, function, and circulation within normal and tumor tissues. Murine tumor models were initially set to study murine NK cells, then, ever more sophisticated human-in-mice models have been developed to investigate the behavior of human NK cells and minimize the interferences from the murine environment. This review presents an overview of the models that have been used along time to study NK cells, focusing on the most popular NOG and NSG models, which work as recipients for the preparation of human-in-mice tumor models, the study of transferred human NK cells, and the evaluation of various enhancers of human NK cell function, including cytokines and chimeric molecules. Finally, an overview of the next generation humanized mice is also provided along with a discussion on how traditional and innovative and approaches could be integrated to optimize effective pre-clinical studies.

摘要

自最初的研究以来,小鼠模型为 NK 细胞的最重要发现提供了关键支持,包括其在正常和肿瘤组织中的发育、功能和循环。最初建立小鼠肿瘤模型是为了研究小鼠 NK 细胞,然后,开发了越来越复杂的人源化小鼠模型来研究人类 NK 细胞的行为,并最大限度地减少来自于小鼠环境的干扰。本文综述了长期以来用于研究 NK 细胞的模型,重点介绍了最受欢迎的 NOG 和 NSG 模型,这些模型可作为制备人源化小鼠肿瘤模型、研究转导的人类 NK 细胞以及评估各种增强人类 NK 细胞功能的因子(包括细胞因子和嵌合分子)的受体。最后,还概述了下一代人源化小鼠,并讨论了如何整合传统和创新方法来优化有效的临床前研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e8/10301748/a21df37a4e34/fimmu-14-1209237-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e8/10301748/a21df37a4e34/fimmu-14-1209237-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48e8/10301748/a21df37a4e34/fimmu-14-1209237-g001.jpg

相似文献

[1]
Murine models to study human NK cells in human solid tumors.

Front Immunol. 2023

[2]
Enhanced development of functional human NK cells in NOD-scid-IL2rg mice expressing human IL15.

FASEB J. 2022-9

[3]
Development of Humanized Mouse Models for Studying Human NK Cells in Health and Disease.

Methods Mol Biol. 2022

[4]
Predominant development of mature and functional human NK cells in a novel human IL-2-producing transgenic NOG mouse.

J Immunol. 2015-4-1

[5]
The Tumor Milieu Promotes Functional Human Tumor-Resident Plasmacytoid Dendritic Cells in Humanized Mouse Models.

Front Immunol. 2020-9-8

[6]
Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors.

J Immunother Cancer. 2021-10

[7]
Real-Time Tracking of -Expanded Natural Killer Cells Toward Human Triple-Negative Breast Cancers.

Front Immunol. 2018-5-2

[8]
Isolation and (111)In-Oxine Labeling of Murine NK Cells for Assessment of Cell Trafficking in Orthotopic Lung Tumor Model.

Mol Pharm. 2016-4-4

[9]
Humanized mouse model supports development, function, and tissue residency of human natural killer cells.

Proc Natl Acad Sci U S A. 2017-10-25

[10]
Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2 pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice.

J Immunother Cancer. 2021-7

引用本文的文献

[1]
Evofosfamide Enhances Sensitivity of Breast Cancer Cells to Apoptosis and Natural-Killer-Cell-Mediated Cytotoxicity Under Hypoxic Conditions.

Cancers (Basel). 2025-6-14

[2]
A Genome-Wide Screening of Novel Immunogenic TrLSDV103 Protein of Lumpy Skin Disease Virus and Its Application for DIVA.

FASEB J. 2025-6-15

本文引用的文献

[1]
Revising the Landscape of Cytokine-Induced Killer Cell Therapy in Lung Cancer: Focus on Immune Checkpoint Inhibitors.

Int J Mol Sci. 2023-3-15

[2]
Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer.

Oncoimmunology. 2023

[3]
A tri-specific killer engager against mesothelin targets NK cells towards lung cancer.

Front Immunol. 2023

[4]
Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity.

Cancer Res Commun. 2023-2

[5]
Humanized mouse models for immuno-oncology research.

Nat Rev Clin Oncol. 2023-3

[6]
Cancer plasticity: Investigating the causes for this agility.

Semin Cancer Biol. 2023-1

[7]
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia.

J Hematol Oncol. 2022-11-5

[8]
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant.

Cell Rep Med. 2022-10-18

[9]
TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity.

J Immunother Cancer. 2022-9

[10]
Chemical priming of natural killer cells with branched polyethylenimine for cancer immunotherapy.

J Immunother Cancer. 2022-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索